Synergistic effect of combined intramyocardial CD34+ cells and VEGF2 gene therapy after MI

Nature Clinical Practice Cardiovascular Medicine

Volumn 3, Issue SUPPL. 1, 2006, Pages

  Shintani, Satoshi ^a,b   Kusano, Kengo ^a   Ii, Masaaki ^a   Iwakura, Atsushi ^a   Heyd, Lindsay ^a   Curry, Cynthia ^a   Wecker, Andrea ^a   Gavin, Mary ^a   Ma, Hong ^a   Kearney, Marianne ^a   Silver, Marcy ^a   Thorne, Tina ^a   Murohara, Toyoaki ^a,b   Losordo, Douglas W ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; CD34+ cells; Endothelial progenitor cells; Ischemia; Vascular endothelial growth factor

Indexed keywords

CD34 ANTIGEN; PROTEIN KINASE B; VASCULOTROPIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAPILLARY DENSITY; CELL TRANSPLANTATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ENDOTHELIUM CELL; FEMALE; GENE THERAPY; HEART INFARCTION; HEART INFARCTION SIZE; IMMUNE DEFICIENCY; IN VIVO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; OUTCOMES RESEARCH; PLASMID; PRIORITY JOURNAL; RANDOMIZATION; RAT; STEM CELL; TREATMENT FAILURE;

ANIMALS; ANTIGENS, CD34; APOPTOSIS; CELLS, CULTURED; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; FEMALE; GENE THERAPY; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, NUDE; TRANSPLANTATION, AUTOLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 33644623600     PISSN: 17434297     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncpcardio0430     Document Type: Article

References (28)

1. Asahara T et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967
2. Takahashi T et al. (1999) Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5: 434-438
3. Yanagisawa-Miwa A et al. (1992) Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 257: 1401-1403
4. Isner JM et al. (1996) Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 348: 370-374
5. Losordo DW et al. (2002) Phase 1/2 placebo-controlled, double-blind dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 105: 2012-2018
6. Autiero M et al. (2003) Role of PIGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 9: 936-943
7. Kawamoto A et al. (2001) Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103: 634-637
8. Kocher AA et al. (2001) Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7: 430-436
9. Kawamoto A et al. (2003) Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107: 461-468
10. Ii M et al. (2005) Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity. Circulation 111: 1114-1120
11. Gnecchi M et al. (2005) Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11: 367-368
12. Tateishi-Yuyama E et al. (2002) Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360: 427-435
13. Kawamoto A et al. (2004) Synergistic effect of bone marrow mobilization and vascular endothelial growth factor-2 gene therapy in myocardial ischemia. Circulation 110: 1398-1405
14. Yamaguchi J et al. (2003) Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107: 1322-1328
15. Yoon YS et al. (2005) Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 115: 326-338
16. Hu J-S et al. (1997) A novel regulatory function of proteolytically cleaved VEGF-2 for vascular endothelial and smooth muscle cells. FASEB J 11: 498-504
17. Witzenbichler B et al. (1998) Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am J Pathol 153: 381-394
18. Dimmeler S et al. (2001) HMG-CoA-reductase inhibitors (statins) increase endothelial progenitor cells via the P13 kinase/Akt pathway. J Clin Invest 108: 391-397
19. Murasawa S et al. (2002) Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation 106: 1133-1139
20. Vasa M et al. (2001) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89: E1-E7
21. Hill JM et al. (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593-600
22. Heeschen C et al. (2004) Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109: 1615-1622
23. + and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation 110: 1209-1212
24. Iwaguro H et al. (2002) Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 105: 732-738
25. Shintani S et al. (2001) Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103: 2776-2769
26. 165 gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 86: 1198-1202
27. Losordo DW and Dimmeler S (2004) Therapeutic angiogenesis and vasCulogenesis for ischemic disease: Part II: cell-based therapies. Circulation 109: 2692-2697
28. Werner N et al. (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353, 999-1007